Legal News: Dangerous Drugs

FDA Sends Warning Letter to Fresenius Regarding Dialysis Product Design
largest provider of dialysis products and services in the United States, did not conduct adequate research into artificial kidneys used in their dialysis machines. Continue Reading

April 10, 2013 | Tags: Dangerous Drugs, GranuFlo

Study Links Januvia, Byetta to Risk of Pancreatitis & Pancreatic Cancer
Recent research has suggested a possible link between the diabetes drugs Januvia and Byetta and a heightened risk of pancreatitis and pancreatic cancer. Continue Reading

April 8, 2013 | Tags: Byetta, Dangerous Drugs, Januvia

FDA Launches Investigation into Januvia, Byetta Pancreatic Cancer Risk
Earlier this month, the FDA announced the launch of an investigation into the potential for an increased risk of pancreatitis and pancreatic cancer linked to an entire family of diabetes medications, including Januvia, Byetta, and Victoza. Continue Reading

April 5, 2013 | Tags: Byetta, Dangerous Drugs, Januvia, Victoza

Growing Number of Fresenius Dialysis Lawsuits as MDL Considered
The number of personal injury and wrongful death lawsuits against Fresenius Medical Care (FMC) continues to grow in the United States.  Continue Reading

March 26, 2013 | Tags: Dangerous Drugs, GranuFlo

Yaz Deep Vein Thrombosis Led to Amputation
In Oklahoma, a woman has filed a lawsuit against Bayer Healthcare based on claims that she needed to have her arm amputated after suffering deep vein thrombosis (DVT) caused by Yaz birth control pill side effects. Continue Reading

March 20, 2013 | Tags: Dangerous Drugs, Yaz

Actos Bladder Cancer Lawsuit Begins
This week, the first of thousands of Actos bladder cancer lawsuits filed by former users of the diabetes drug is set to begin. Continue Reading

March 5, 2013 | Tags: Actos, Dangerous Drugs

Fresenius in Favor of GranuFlo, NaturaLyte MDL
Fresenius Medical Care (FMC) has gone on record in support of consolidating all federal GranuFlo and NaturaLyte lawsuits into a multidistrict litigation, or MDL. Continue Reading

Feb. 18, 2013 | Tags: Dangerous Drugs, GranuFlo

Pradaxa Settlement Negotiations Planned
The first federal Pradaxa trials are set to begin in 2014, and lawyers involved in these cases are slated to meet to discuss potential settlement agreements later this year. Continue Reading

Feb. 4, 2013 | Tags: Dangerous Drugs, Pradaxa

Studies on Drugs, Medical Devices are Often Biased
A recent study found that clinical studies that are sponsored by medical device manufacturers or pharmaceutical companies are often biased in that company’s favor.  Continue Reading

Jan. 11, 2013 | Tags: Dangerous Drugs, Dangerous Medical Devices, Defective Medical Devices

Fresenius Dialysis Malpractice Lawsuit Filed
In Ohio, Adda M. Paxon and her husband Gayle have filed a personal injury lawsuit against a Fresenius dialysis center based on claims of medical malpractice. Continue Reading

Jan. 8, 2013 | Tags: Dangerous Drugs, GranuFlo

GranuFlo Cardiac Arrest Lawsuit Filed
In Ohio, the family of a man who died of cardiac arrest after dialysis treatment with GranuFlo has filed a wrongful death lawsuit against Fresenius Medical Care. Continue Reading

Dec. 27, 2012 | Tags: Dangerous Drugs, GranuFlo

Pradaxa and Warfarin: FDA Evaluation Leads to Questions
According to federal drug regulators, Pradaxa and warfarin present comparable risks of internal bleeding. Continue Reading

Nov. 26, 2012 | Tags: Dangerous Drugs, Pradaxa

Pradaxa Recall Issued
A recall has been issued for one lot of the anticoagulant Pradaxa because problems with the bottles have the potential to affect the drug’s effectiveness. Continue Reading

Nov. 13, 2012 | Tags: Dangerous Drugs, Pradaxa

GranuFlo Class 1 Recall
Based on a high number of reports of patient injuries, side effects, and deaths, the FDA has issued a Class 1 recall of its GranuFlo product. Continue Reading

Oct. 23, 2012 | Tags: Dangerous Drugs, GranuFlo

GranuFlo Recall Information
In March 2012, the FDA issued a Class 1 recall (the most serious level of recall) for GranuFlo, a dialysis product made by Fresenius Medical Care (FMC). Continue Reading

Oct. 17, 2012 | Tags: Dangerous Drugs, GranuFlo

Fresenius GranuFlo Dialysis Death Lawsuit
In Georgia, Waddell Bishop has filed a wrongful death lawsuit against Fresenius Medical Care after his mother suffered a fatal heart attack after dialysis treatment with the company’s GranuFlo and NaturaLyte products. Continue Reading

Oct. 15, 2012 | Tags: Dangerous Drugs, GranuFlo

Dialysis Heart Attack Risk
Thousands of individuals have experienced cardiac arrest, stroke, or heart attack after dialysis treatment with GranuFlo and NaturaLyte. Continue Reading

Oct. 11, 2012 | Tags: Dangerous Drugs, GranuFlo

List of Meningitis Drug Outbreak Recalls Grows
The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are working in tandem to learn more about the injectable drugs that have been linked to a deadly outbreak of meningitis, affecting 47 victims in 7 states so far. Continue Reading

Oct. 9, 2012 | Tags: Dangerous Drugs, Meningitis

Patient Killed by Single Dose of Pradaxa
In April 2012, the Journal of Clinical Toxicology published a report of a 92-year-old patient who died after taking Pradaxa for only one day. Continue Reading

Oct. 4, 2012 | Tags: Dangerous Drugs, Pradaxa

Lawyers Apply for Leadership Roles in Pradaxa MDL
As the structure of the proceedings in the Pradaxa MDL (multidistrict litigation) is established, plaintiff’s attorneys are seeking leadership roles in the case Continue Reading

Oct. 3, 2012 | Tags: Dangerous Drugs, Pradaxa

First Federal Pradaxa MDL Conference Scheduled
In an initial status conference set for early October, the judge recently appointed to preside over federal Pradaxa lawsuit litigation in an MDL will meet with lawyers involved in these cases. Continue Reading

Sept. 18, 2012 | Tags: Dangerous Drugs, Pradaxa

Patient Killed by Single Dose of Pradaxa
In April 2012, the Journal of Clinical Toxicology published a report of a 92-year-old patient who died after taking Pradaxa for only one day Continue Reading

Sept. 12, 2012 | Tags: Dangerous Drugs, Pradaxa

Yet Another Study Connects Long-Term Use of Actos to Bladder Cancer
A study published this week in the Journal of the National Cancer Institute is just one of many to confirm a link between the diabetes drug Actos and bladder cancer. Continue Reading

Aug. 23, 2012 | Tags: Actos, Dangerous Drugs

Did Fresenius Medical Care Display Negligence in Violating Rules and Failing to Alert?
Fresenius Medical Care failed to warn many doctors that their product, GranuFlo, could lead to heart attacks in dialysis patients.  The company is now being investigated for negligence. Continue Reading

Aug. 20, 2012 | Tags: Dangerous Drugs, GranuFlo

Inquiry Arises after Dialysis Company’s Failure to Warn
The FDA is currently investigating whether Fresenius Medical Care, the nation’s largest owner and operator of dialysis centers, exhibited negligence and broke the law by failing to inform doctors and patients of the potentially fatal risk associated with one of its products. Continue Reading

Aug. 9, 2012 | Tags: Dangerous Drugs, GranuFlo

Pending Consolidation, Pradaxa Suits Increase
At this point, records show roughly 50 Pradaxa complaints spread across more than twenty U.S. District Courts. Continue Reading

July 31, 2012 | Tags: Dangerous Drugs, Pradaxa

Despite Risks, Pradaxa May Become More Popular than Warfarin
An update to Pradaxa labels may increase use over Coumadin (warfarin), in spite of press about hundreds of deaths and thousands of reports of internal bleeding in Pradaxa patients only two years after the anticoagulant was released. Continue Reading

July 24, 2012 | Tags: Dangerous Drugs, Pradaxa

Another Study Identifies Actos Bladder Cancer Side Effects
Side effects linking the diabetes drug Actos to bladder cancer have been identified by yet another study. Continue Reading

July 18, 2012 | Tags: Actos, Dangerous Drugs

Zoloft Atrial Septal Defect Lawsuit
In Massachusetts, a 21-year-old woman has filed a Zoloft heart birth defect lawsuit against Pfizer. Continue Reading

July 13, 2012 | Tags: Birth Defects, Craniosynostosis, Dangerous Drugs, PPHN, Spina Bifida, Zoloft

Another Study Identifies Actos Bladder Cancer Side Effects
A new study has linked Actos to bladder cancer. Continue Reading

July 9, 2012 | Tags: Actos, Dangerous Drugs

Study: Pradaxa and Warfarin Post Surgery Bleeding Rates Similar
Findings from a new study indicate similar rates for bleeding and thromboembolic complications between Pradaxa and warfarin patients when these patients need to undergo surgery. Continue Reading

July 3, 2012 | Tags: Dangerous Drugs, Pradaxa

Pradaxa Bleeding Reversal May Be Possible
In a new study, researchers have identified possible ways to stop internal bleeding caused by a proposed blood thinner that belongs to the same class of drugs as Pradaxa Continue Reading

July 2, 2012 | Tags: Dangerous Drugs, Pradaxa

Drug Maker Supports Pradaxa Lawsuit Consolidation
Boehringer Ingelheim has responded to a plaintiffs’ request to centralize all Pradaxa lawsuits, indicating that the pharmaceutical manufacturer is in support of consolidating all pretrial litigation before one judge. Continue Reading

June 28, 2012 | Tags: Dangerous Drugs, Pradaxa

Research Links More Problems to Antidepressants during Pregnancy
Recent research has raised additional questions about the safety of using antidepressants such as Paxil, Zoloft, and Celexa during pregnancy. Continue Reading

June 13, 2012 | Tags: Birth Defects, Celexa, Craniosynostosis, Dangerous Drugs, Omphalocele, Paxil, PPHN, Septal Heart Defects, Spina Bifida, Zoloft

Pradaxa Tops FDA Adverse Event Reports in 2011
According to the FDA’s Adverse Events reporting system, the blood thinner Pradaxa was the cause of hundreds of deaths last year in the United States.  Continue Reading

June 12, 2012 | Tags: Dangerous Drugs, Pradaxa

Study Clarifies Risk of Actos Bladder Cancer
Researchers from Canada have concluded that taking Actos for more than two years doubles a person’s risk of developing bladder cancer.  Continue Reading

June 8, 2012 | Tags: Actos, Dangerous Drugs

Study Links Fosamax to Esophageal Cancer
A recently released study has linked the osteoporosis drug Fosamax with a heightened risk of esophageal cancer. Continue Reading

June 6, 2012 | Tags: Dangerous Drugs, Fosamax

Zithromax Lawsuit
Zithromax, also known as Z-Pak or generic azithromycin, is a popular antibiotic that has been linked to a heightened risk of heart rhythm problems and heart-related death. Continue Reading

May 29, 2012 | Tags: Dangerous Drugs, Zithromax

Study: Coumadin Safer Than Pradaxa
Preliminary data from an in-progress study indicate that the time-tested blood thinner Coumadin (warfarin) could be safer than newer anticoagulants such as Pradaxa. Continue Reading

May 23, 2012 | Tags: Dangerous Drugs, Pradaxa

Study Finds SSRI Antidepressants Do More Harm Than Good
Wide-spread use of SSRI antidepressants has been called into question by a new study that concluded that the side effects associated with these drugs outweigh the benefits, and that the drugs do more harm than good.  Continue Reading

May 15, 2012 | Tags: Birth Defects, Dangerous Drugs, Paxil, Zoloft

FDA Rejects New Diabetes Drug with Actos
Two new Takeda Pharmaceuticals diabetes drugs which contain a new treatment as well as Actos have been rejected by the FDA. Continue Reading

May 14, 2012 | Tags: Actos, Dangerous Drugs

Pradaxa Sales Grow in Spite of Internal Bleeding Problems
Despite hundreds of deaths and hospitalizations caused by Pradaxa internal bleeding, sales of the relatively new blood thinner have skyrocketed to reach blockbuster status in recent months.  Continue Reading

May 11, 2012 | Tags: Dangerous Drugs, Pradaxa

Dr. Speaks on Actos Bladder Cancer Whistleblower Lawsuit
In a recently unsealed qui tam lawsuit, Dr. Helen Ge revealed fraud and negligence on the part of Takeda Pharmaceuticals, maker of the popular diabetes drug Actos. Continue Reading

May 7, 2012 | Tags: Actos, Dangerous Drugs, Whistleblower

Canada Adds Actos Bladder Cancer Risk Warning
In Canada, health officials have issued new warnings about the risk of Actos bladder cancer associated with the drug used to treat Type II Diabetes. Continue Reading

May 3, 2012 | Tags: Actos, Dangerous Drugs

Federal Consolidation of Zoloft Birth Defect Lawsuits
On April 17, a panel of federal judges ordered the consolidation of all federal Zoloft birth defect lawsuits filed in the United States. Continue Reading

May 2, 2012 | Tags: Birth Defects, Craniosynostosis, Dangerous Drugs, Omphalocele, PPHN, Septal Heart Defects, Zoloft

Warfarin Remains Popular after Pradaxa Bleeding Charges
Recent research supporting the efficacy of Coumadin (warfarin) in the prevention of strokes may mean a further setback to Pradaxa, a competing blood thinner. Continue Reading

April 24, 2012 | Tags: Dangerous Drugs, Pradaxa

Older Patients Continue to Experience Pradaxa Hemorrhages and Overdoses
A new report on Pradaxa problems submitted to the FDA states that the controversial drug may have been responsible for 117 more deaths in the second quarter of 2011. Continue Reading

April 19, 2012 | Tags: Dangerous Drugs, Pradaxa

Pradaxa Internal Bleeding Concerns Mount after Patient Dies
After an elderly man died from a brain hemorrhage, the Journal of Neurosurgery has suggested that Pradaxa internal bleeding is largely irreversible. Continue Reading

April 13, 2012 | Tags: Dangerous Drugs, Pradaxa

Pradaxa Shortfalls Mean Warfarin Will Likely Remain Popular
While makers of Pradaxa try to gain market share from an alternative drug, warfarin, mounting concerns about the safety of Pradaxa have dealt a significant setback. Continue Reading

April 11, 2012 | Tags: Dangerous Drugs, Pradaxa

New Blood Thinner Similar to Pradaxa: Risk of Internal Bleeding
Merck & Co. has introduced a new blood thinner which is in the same class as Pradaxa and Xarelto, which also poses an increased risk of potentially fatal internal bleeding. Continue Reading

April 9, 2012 | Tags: Dangerous Drugs, Pradaxa

Canada Updates Pradaxa Warnings for Kidney Patients
In Canada, public health officials have changed warnings on labels for the blood thinner Pradaxa (Pradax in Canada) so that they reflect an increased risk of internal bleeding for patients who have kidney problems. Continue Reading

April 2, 2012 | Tags: Dangerous Drugs, Pradaxa

Pradaxa Review Delayed by Concerns about Safety of the Anticoagulant
The FDA has called for a  delay to its review of Eliquix, a blood thinner in the same class as Pradaxa amidst fears of the likelihood of Pradaxa internal bleeding. Continue Reading

March 28, 2012 | Tags: Dangerous Drugs, Pradaxa

Actos Judge Appointed in Multidistrict Litigation
Judge Jane L. Johnson of the Los Angeles County Superior Court has been appointed to preside over pretrial proceedings of the 22 California state court Actos lawsuits that have now been consolidated. Continue Reading

March 26, 2012 | Tags: Actos, Dangerous Drugs

Pradaxa Website Information Violates ABPI Code of Conduct
Boehringer Ingelheim, the maker of Pradaxa, has been cited for improperly providing information by a British regulatory agency. Continue Reading

March 23, 2012 | Tags: Dangerous Drugs, Pradaxa

Whistleblower (Qui Tam) Lawsuit: Actos Heart Problems Kept from FDA
According to a recent whistleblower lawsuit, Takeda Pharmaceuticals hid evidence about the association of their drug, Actos, with congestive heart failure and the death of some Actos patients. Continue Reading

March 22, 2012 | Tags: Actos, Dangerous Drugs

Report on Pradaxa Brain Hemorrhage Highlights Risks with Heart Drug
A recently published study highlights the fact that the lack of a reversal method to stop Pradaxa internal bleeding is adding to the fatality count associated with this drug. Continue Reading

March 20, 2012 | Tags: Dangerous Drugs, Pradaxa

Fatal G.I. Hemorrhage Prompts Pradaxa Wrongful Death Lawsuit
After her death from a severe gastrointestinal bleed, the family of a Tennessee woman has filed a wrongful death lawsuit against Pradaxa maker Boehringer Ingelheim. Continue Reading

March 15, 2012 | Tags: Dangerous Drugs, Pradaxa

American Stroke Association Investigates Xarelto, Pradaxa Health Risks
To gauge the affect of new drugs on health and stroke risks, stroke experts have announced that they plan to review the safety of Pradaxa and similar blood thinners. Continue Reading

March 7, 2012 | Tags: Dangerous Drugs, Pradaxa

Pradaxa Bleeding a Risk to the Elderly
In a letter to the editor of the New England Journal of Medicine, a group of New Zealand doctors raised questions about the safety of dabigatran (Pradaxa in the United States) when given to elderly patients. Continue Reading

March 6, 2012 | Tags: Dangerous Drugs, Pradaxa

Leadership Roles Sought by Actos Lawyers in Federal MDL
Lawyers who wish to pursue a committee position or leadership role within the consolidated multidistrict litigation (MDL) of Actos bladder cancer lawsuits have been invited by the presiding judge to submit information on their qualifications before a hearing set for next month. Continue Reading

March 1, 2012 | Tags: Actos, Dangerous Drugs

Lawyers Want Zoloft Cases Remanded to State Court
Zoloft lawyers are claiming that dozens of dangerous drug lawsuits were incorrectly moved from state court systems in motions filed last week opposing Pfizer’s attempt to consolidate all pending Zoloft birth defect claims in federal court. Continue Reading

Feb. 28, 2012 | Tags: Birth Defects, Craniosynostosis, Dangerous Drugs, Omphalocele, PPHN, Septal Heart Defect, Spina Bifida, Zoloft

Pradaxa Bleeding Risk Higher when Compared to Warfarin
Based on a recent study, researchers suggest that Pradaxa side effects may make the risk of internal bleeding events even more likely than the drug it was meant to replace, warfarin. Continue Reading

Feb. 23, 2012 | Tags: Dangerous Drugs, Pradaxa

Xarelto may Present Bleeding Problems like Pradaxa
According to a recent study, the anticoagulant drug Xarelto may present less of a stroke risk than other blood thinners, but it could also carry bleeding risks associated with Pradaxa and other anti-clotting drugs. Continue Reading

Feb. 17, 2012 | Tags: Dangerous Drugs, Pradaxa

Propecia Information Removed from Merck Website
After Merck removed their website dedicated to Propecia information from the Internet, there is heightened speculation as to whether the company will issue new warnings about sexual problems associated with the hair-loss drug. Continue Reading

Feb. 16, 2012 | Tags: Dangerous Drugs, Propecia

Lawsuits Claim Pfizer Knew of Zoloft Birth Defects Risks
In Louisiana, two couples have filed suit against drug maker Pfizer, alleging that the company knew of the risk of Zoloft birth defects when the drug is taken by pregnant women, but did not alert the public to this risk. Continue Reading

Feb. 15, 2012 | Tags: Birth Defects, Dangerous Drugs, Omphalocele, PPHN, Septal Heart Defect

California Court Remands Actos Bladder Cancer Lawsuit
In California, a man has won the right to maintain his Actos bladder cancer lawsuit in California state court.  This case could impact dozens of other Actos litigation cases. Continue Reading

Feb. 14, 2012 | Tags: Actos, Dangerous Drugs

Zoloft Birth Defect Litigation to be Consolidated by Pfizer
A motion has been filed by Pfizer requesting that all federal Zoloft birth defect lawsuits be consolidated into a multidistrict litigation, or MDL. Continue Reading

Feb. 10, 2012 | Tags: Birth Defects, Craniosynostosis, Dangerous Drugs, Omphalocele, PPHN, Septal Heart Defects, Zoloft

Takeda Cuts Work Force amid Actos Concerns
After recently acquiring the Swiss drug company Nycomed and amidst concerns over sales of Actos, Takeda Pharmaceuticals has stated that they plan to cut 2,800 jobs in the U.S. and in Europe. Continue Reading

Feb. 9, 2012 | Tags: Actos, Avandia, Dangerous Drugs

Cymbalta Stevens-Johnson Syndrome Lawsuit in Kansas: Eli Lilly
In Kansas, a woman has filed a dangerous medication lawsuit against Eli Lilly and Co. after a reaction to Cymbalta caused her to develop Stevens-Johnson Syndrome. Continue Reading

Jan. 30, 2012 | Tags: Cymbalta, Dangerous Drugs, Stevens Johnson Syndrome

Actos Still Valid Treatment in Spite of Bladder Cancer Risk
In Europe, health officials have deemed that Actos is a valid diabetes treatment in spite of numerous reports regarding the risk of bladder cancer for Actos users. Continue Reading

Jan. 27, 2012 | Tags: Actos, Dangerous Drugs

Pradaxa Bleeding Problems: More than 500 Reported in 2011 First Quarter
In just the first quarter of 2011, the FDA has received more than 500 reports of Pradaxa bleeding problems. Continue Reading

Jan. 26, 2012 | Tags: Dangerous Drugs, Pradaxa

Actos Bladder Cancer Lawsuits Coordinated in CA State Court
All Actos bladder cancer lawsuits filed in California state court will be consolidated and coordinated for pretrial proceedings. Continue Reading

Jan. 18, 2012 | Tags: Actos, Dangerous Drugs

DES Linked to Breast Cancer: Boston Lawsuit
Since the 1970s, thousands of women have filed DES lawsuits based on alleged links between the drug and cervical and vaginal cancer, as well as infertility problems. Continue Reading

Jan. 17, 2012 | Tags: Dangerous Drugs, DES

Pregnancy Drug DES Breast Cancer Lawsuit Filed
In Boston, a woman has filed suit against drug makers who manufactured the discontinued pregnancy drug DES based on the claim that the drug her mother took during pregnancy caused the plaintiff to develop breast cancer as an adult. Continue Reading

Jan. 13, 2012 | Tags: Dangerous Drugs, DES

Motion Filed to Consolidate Propecia Sexual Dysfunction Lawsuits
A number of Propecia lawsuits have been filed by American men who experienced erectile dysfunction or other sexual problems after taking this hair-loss drug, and now a plaintiff has called for the consolidation of all federal Propecia lawsuits.   Continue Reading

Jan. 1, 2012 | Tags: Dangerous Drugs, Personal Injury, Propecia

Lexapro and Birth Defects
  Recent studies have linked Lexapro and other antidepressants to serious birth defects. Lexapro is an FDA Pregnancy Category C drug, which signifies a high risk of birth defects are associated with this drug. However, Lexapro is still prescribed to a large number of pregnant women. Included in the long list of potential Lexapro birth defects are craniosynostosis, congenital heart defects, and oral cleft birth defects such as cleft lip and cleft palate.   Continue Reading

Dec. 28, 2011 | Tags: Birth Defects, Craniosynostosis, Dangerous Drugs, Lexapro, PPHN, Septal Heart Defects

Effexor Dangerous Drug Lawsuits
Effexor (venlafaxine) is a popular treatment for anxiety disorders and depression, and is also used off-label to treat migraines, diabetic neuropathy, and menopausal hot flashes. Unfortunately, Effexor has been linked to a number of serious birth defects when taken during pregnancy. Continue Reading

Dec. 21, 2011 | Tags: Drugs

California Actos Bladder Cancer Lawsuit Moves to Federal Court
A recently filed California Actos bladder cancer lawsuit has been moved to federal court by Takeda Pharmaceuticals, the drug manufacturer. Continue Reading

Dec. 18, 2011 | Tags: Actos, Dangerous Drugs

Actos Lawsuit Coordination Requested by California Lawyer
A recent Actos lawsuit case evaluation involved nine suits filed in California within 60 days.  As a result, an Actos lawyer has requested that all nine of these claims be coordinated into an Actos mass tort. Continue Reading

Dec. 15, 2011 | Tags: Actos, Dangerous Drugs

Parents of 8 Children File Zoloft Birth Defect Lawsuits
A product liability suit against Pfizer was filed by the parents of eight children who were born with severe birth defects after their mothers took Zoloft during pregnancy. Continue Reading

Dec. 8, 2011 | Tags: Birth Defects, Dangerous Drugs, Omphalocele, PPHN, Septal Heart Defects, Zoloft

Zoloft Birth Defects Prompt Lawsuits
Many women whose babies were born with Zoloft birth defects such as craniosynostosis, PPHN, or omphalocele have opted to file dangerous drug lawsuits in pursuit of compensation for medical bills and other damages. Continue Reading

Dec. 6, 2011 | Tags: Birth Defects, Craniosynostosis, Dangerous Drugs, Omphalocele, PPHN, Septal Heart Defects, Zoloft

Mother Files Zoloft Lawsuit after Child Born with Heart Defects
Cheri D. Lewis, of Texas, filed a Zoloft lawsuit on October 36, 2011 in an effort to collect compensation for medical bills after her child was born with multiple heart defects, including hypoplastic left heart syndrome, as a result of exposure to Zoloft during pregnancy. Continue Reading

Dec. 2, 2011 | Tags: Birth Defects, Dangerous Drugs, PPHN, Septal Heart Defect, Zoloft

“Do Not Use” List: Actos Diabetes Drug
On the heels of an increasing number of Actos bladder cancer lawsuits, the non-profit consumer advocacy group Public Citizen recently reinforced their decision to add the diabetes drug Actos to their “Do Not Use” list. Continue Reading

Dec. 1, 2011 | Tags: Actos, Avandia, Dangerous Drugs

Study Seeks Clomid Birth Defect Link
To date, studies attempting to link Clomid with certain birth defects have been inconclusive, but research recently published online in the journal Human Reproduction has linked Clomid to nine types of birth defects. Continue Reading

Nov. 28, 2011 | Tags: Birth Defects, Clomid, Dangerous Drugs, Omphalocele, Septal Heart Defect, Spina Bifida

Acetaminophen/Tylenol Lawsuits
Scientific studies have linked high dosages of acetaminophen, the active ingredient in Tylenol and other over-the-counter pain killers, to a heightened risk of liver damage and liver failure. Continue Reading

Nov. 23, 2011 | Tags: Acetaminophen, Dangerous Drugs, Tylenol

More Propecia Sexual Dysfunction Lawsuits Filed
A growing number of men have recently filed Propecia sexual side effects lawsuits, claiming to have suffered infertility, impotence, erectile dysfunction, and other permanent sexual problems after taking Merck’s prescription medication to treat male pattern baldness. Continue Reading

Nov. 22, 2011 | Tags: Dangerous Drugs, Propecia

Recent Actos Lawsuit: Wrongful Death Blamed on Drug
Takeda Pharmaceuticals is again under scrutiny regarding the popular diabetes drug Actos. Continue Reading

Nov. 16, 2011 | Tags: Actos, Dangerous Drugs

No Actos Recall In Europe
In Europe, drug regulators have decided not to recommend an Actos recall, despite the established link between the diabetes drug and bladder cancer. Continue Reading

Nov. 9, 2011 | Tags: Actos, Dangerous Drugs

Depakote Spina Bifida Birth Defect Lawsuit Filed
In Illinois, a mother has filed a dangerous drug lawsuit against Abbott Laboratories on the grounds that her daughter suffered a spina bifida birth defect after the mother took Depakote during pregnancy. Continue Reading

Nov. 8, 2011 | Tags: Birth Defects, Dangerous Drugs, Depakote

Actos Drug Combo Launched in Japan by Takeda
On September 20, 2011, Takeda Pharmaceuticals announced the launch of Liovel, a fixed-dose combination of Nesina (alogliptin) and Actos (pioglitazone) for the treatment of type II diabetes in Japan, despite a growing number of Actos bladder cancer lawsuits being filed in the United States. Continue Reading

Nov. 3, 2011 | Tags: Actos, Dangerous Drugs

Stevens-Johnson Syndrome Motrin Lawsuit Results in $48 Million Award
In Los Angeles, a jury has awarded $48.1 million to a man who suffered Stevens-Johnson syndrome after taking Motrin as a teenager. Stevens-Johnson syndrome is a debilitating and potentially life-threatening rash. Continue Reading

Nov. 2, 2011 | Tags: Dangerous Drugs, Personal Injury, Stevens Johnson Syndrome

FDA Scrutiny and Lawsuits Prompted by Zoloft
Zoloft, a popular antidepressant, may lead to serious and potentially fatal birth defects such as Zoloft PPHN (Persistent Pulmonary Hypertension in Newborns).  These complications have led to FDA scrutiny and a number of Zoloft birth defect lawsuits filed against Pfizer. Continue Reading

Nov. 1, 2011 | Tags: Birth Defects, Dangerous Drugs, Omphalocele, PPHN, Zoloft

Actos Bladder Cancer Litigation Consolidation: MDL Panel Set to Meet
An MDL panel of federal judges is preparing to make the decision whether to consolidate the federal Actos bladder cancer litigation before one judge for pretrial management. Continue Reading

Oct. 31, 2011 | Tags: Actos, Avandia, Dangerous Drugs

Propecia Sexual Side Effects Lawsuit
In Colorado, a Propecia sexual side effects lawsuit has been filed against Merck & Co., based on the allegation that the plaintiff suffered erectile dysfunction and other permanent sexual problems after taking the popular hair loss drug. Continue Reading

Oct. 28, 2011 | Tags: Dangerous Drugs, Personal Injury, Propecia

Ohio Zoloft Birth Defect Lawsuit
An Ohio couple has filed a Zoloft birth defect lawsuit, based on the allegation that use of the popular antidepressant during pregnancy caused their child to be born with a neural tube birth defect known as anencephaly.  Continue Reading

Oct. 27, 2011 | Tags: Birth Defects, Dangerous Drugs, Omphalocele, PPHN, Septal Heart Defect, Zoloft

FDA Pradaxa Warning: Do Not Remove Blood Thinner from Bottle
The FDA warns that the Pradaxa, a blood thinner, will begin to break down if removed from its original blister packaging or bottle, and needs to be used a relatively short time after it is opened. Continue Reading

Oct. 25, 2011 | Tags: Dangerous Drugs, Personal Injury, Pradaxa

Zoloft Birth Defect Lawsuit Filed
In Ohio, a couple has filed a Zoloft birth defect lawsuit after their son was born with a fatal birth defect following the mother’s use of Zoloft during pregnancy. Continue Reading

Oct. 24, 2011 | Tags: Birth Defects, Dangerous Drugs, PPHN, Septal Heart Defect, Zoloft

Avodart, Proscar May Cause Prostate Cancer: Warning
Men are warned not to use the Avodart, Proscar, or similar drugs to treat enlarged prostate due to an increased risk of prostate cancer, says the prominent consumer advocacy group Public Citizen. Continue Reading

Oct. 21, 2011 | Tags: Avodart, Dangerous Drugs, Personal Injury, Propecia, Proscar

Actos Bladder Cancer Class Action Lawsuit
Users of the diabetes drug Actos have filed a lawsuit against Takeda Pharmaceuticals and Eli Lily in pursuit of compensation and medical monitoring after the drug makers failed to adequately warn about the risk of bladder cancer from Actos. Continue Reading

Oct. 19, 2011 | Tags: Actos, Dangerous Drugs, Personal Injury

Takeda Actos Attorneys Support Bladder Cancer Litigation Consolidation
Takeda Pharmaceuticals lawyers have stated that they support a request to consolidate all federal Actos bladder cancer lawsuits for pretrial litigation, but they disagree about where the claims should be centralized. Continue Reading

Oct. 12, 2011 | Tags: Actos, Avandia, Dangerous Drugs

European Medicines Agency (EMA) Recommends Restricted Prescription of Multaq
Increased risk of liver injury, lung side effects, and cardiovascular events have been cited as the reasons behind the EMA recommendation that Multaq (dronedarone) be restricted to certain patients with paroxysmal or persistent atrial fibrillation. Continue Reading

Sept. 30, 2011 | Tags: Dangerous Drugs, Multaq, Personal Injury

Actos Bladder Cancer Lawsuits Mount
Actos bladder cancer lawsuit filings by people who have developed bladder cancer after taking the drug used to treat type 2 diabetes are increasing in number. Continue Reading

Sept. 29, 2011 | Tags: Actos, Dangerous Drugs, Personal Injury

Lexapro May Lead to PPHN
In some cases, Lexapro and other SSRI antidepressants taken during pregnancy can lead to PPHN (Persistent Pulmonary Hypertension in Newborns) birth defects. Continue Reading

Sept. 28, 2011 | Tags: Birth Defects, Dangerous Drugs, Lexapro, PPHN

Lexapro: Hold Negligent Manufacturers Responsible
A number of doctors, patients, and advocates are calling for the makers of Lexapro to be held responsible to compensate families affected by Lexapro pregnancy side effects. Continue Reading

Sept. 26, 2011 | Tags: Birth Defects, Dangerous Drugs, Lexapro, Omphalocele, PPHN, Septal Heart Defect

$25 Million Award Upheld in Accutane IBD Lawsuit
In New Jersey, a judge has declined Roche’s request for a new trial or a lesser jury award than $25 million for a man who developed severe inflammatory bowel disease after taking Accutane. Continue Reading

Sept. 22, 2011 | Tags: Accutane, Dangerous Drugs, Personal Injury

Medical Journal Highlights Multaq Liver Failure
The risk of liver failure from Multaq, a relatively new heart drug that has been linked to a heightened risk of liver damage and heart problems, has been reported in a recently published case report. Continue Reading

Sept. 13, 2011 | Tags: Dangerous Drugs, Multaq, Personal Injury

Lawsuit: Actos Bladder Cancer
Patients and doctors who use and prescribe the Type 2 Diabetes drug Actos (Pioglitazone) have become concerned amid recent activity by the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Continue Reading

Sept. 1, 2011 | Tags: Actos, Dangerous Drugs, Personal Injury

Canada Calls for New Propecia Side Effect Warning
A new warning about the risk of male breast cancer from Propecia and Proscar has been issued by Canadian officials. Continue Reading

Aug. 31, 2011 | Tags: Dangerous Drugs, Personal Injury, Propecia

Actos Bladder Cancer Lawsuits Progress
The number of Actos bladder cancer lawsuits in the U.S. is expected to increase by the thousands in the near future. Continue Reading

Aug. 25, 2011 | Tags: Actos, Dangerous Drugs, Personal Injury

Propecia & Proscar Users Report Male Breast Cancer
On August 4, 2011, Health Canada issued an information update alerting the public to a new drug safety issue: the possibility of a male breast cancer diagnosis after taking Propecia and Proscar (finasteride). Continue Reading

Aug. 24, 2011 | Tags: Dangerous Drugs, Personal Injury, Propecia

FDA Approves Actos Bladder Cancer Warning
New warning language concerning the risk of Actos bladder cancer has been approved by the FDA. Continue Reading

Aug. 15, 2011 | Tags: Actos, Dangerous Drugs, Personal Injury

Chantix Side Effect: Risk of Heart Attack
Chantix users are susceptible to a number of side effects including a heightened risk of heart attacks. Continue Reading

July 22, 2011 | Tags: Chantix, Dangerous Drugs, Personal Injury

Propecia Sexual Problems Lawsuit
Drug manufacturer Merck is facing a dangerous medications lawsuit alleging that, while European men were warned that the hair loss and prostate drug Propecia may cause sexual problems, American men did not get the same warning. Continue Reading

July 21, 2011 | Tags: Dangerous Drugs, Propecia

France Issues Actos Recall: Bladder Cancer Risks
France has issued an Actos recall as a result of concerns over a heightened risk of bladder cancer for patients who use the popular diabetes drug made by Takeda Pharmaceuticals. Continue Reading

July 20, 2011 | Tags: Actos, Dangerous Drugs

Propecia Lawsuit Cites Erectile Dysfunction
A product liability lawsuit has been filed against Merck by a Florida man who claims that his sex life was ruined by the side effects of Propecia, a popular hair loss drug. Continue Reading

July 18, 2011 | Tags: Dangerous Drugs, Personal Injury

Concerns About Actos Bladder Cancer Spread Across Europe
Last week, French and German officials suspended the diabetes drug Actos as a result of reports linking Actos to a higher rate of bladder cancer. Continue Reading

July 15, 2011 | Tags: Actos, Dangerous Drugs

Multaq Taken out of Trials: Heart Problems Too Dangerous
Multaq has caused so many cardiovascular events in study participants that the manufacturer was forced to end clinical trials as a result of concerns for patients’ safety. Continue Reading

July 14, 2011 | Tags: Dangerous Drugs

Celexa Linked to Serious Birth Defects
In recent months, increasing light has been shed on the association between the antidepressant Celexa and birth defects. Continue Reading

July 13, 2011 | Tags: Birth Defects, Celexa, Dangerous Drugs, Omphalocele, PPHN, Septal Heart Defect

Zoloft Can Cause Heart Murmurs
The SSRI antidepressant drug Zoloft has been linked to a higher incidence of heart murmurs in babies when taken by pregnant women. Continue Reading

July 12, 2011 | Tags: Birth Defects, Dangerous Drugs, Zoloft

Canada Reviews Chantix Heart Problems
In Canada, an official review has been launched to investigate the potential risk of heart problems associated with Chantix, a popular smoking cessation drug made by Pfizer.  Continue Reading

July 11, 2011 | Tags: Chantix, Dangerous Drugs

FDA Issues Chantix Heart Attack Warning
Federal regulators have required that new warnings be placed on the label for the stop-smoking drug Chantix, which has been associated with an increased risk of heart attacks and other heart problems. Continue Reading

July 7, 2011 | Tags: Dangerous Drugs

Lexapro Risk: Congenital Birth Defects
Lexapro is an antidepressant that is also used to treat anxiety disorders and as a smoking cessation aid.  Lexapro has been linked to a risk of serious birth defects when taken by pregnant women. Continue Reading

July 6, 2011 | Tags: Birth Defects, Dangerous Drugs

FDA Zoloft Drug Alert: Side Effects Risk
The FDA issued a drug alert for the antidepressant Zoloft, warning pregnant women who take Zoloft of the risk of PPHN birth defects in newborns exposed to this drug in the womb. Continue Reading

July 5, 2011 | Tags: Birth Defects, Dangerous Drugs, Zoloft

Topamax Lawsuits
Increasing reports link the anti-seizure drug Topamax (topiramate) to serious cleft palate and cleft lip birth defects. Continue Reading

July 1, 2011 | Tags: Birth Defects, Dangerous Drugs, Topamax

Diabetes Drug Actos Poses Risk of Bladder Cancer
The risk of bladder cancer may be increased by side effects of Actos, a popular diabetes drug. Continue Reading

June 30, 2011 | Tags: Dangerous Drugs

Zoloft Use during Pregnancy has Risen, Despite Risk of Birth Defects
Despite reports of birth defects risks, Zoloft use during pregnancy has increased by about 200% in recent years. Continue Reading

June 29, 2011 | Tags: Birth Defects, Dangerous Drugs, Zoloft

FDA Actos Bladder Cancer Warning
According to a new FDA warning, the side effects of Actos may increase the risk of bladder cancer when the drug is taken for more than a year. Continue Reading

June 28, 2011 | Tags: Dangerous Drugs

FDA Warning on High Dose Simvastatin after Zocor Side Effect Injuries
Simvastatin, marketed as Zocor, is the subject of a new FDA safety warning after high doses of Zocor have been shown to carry an increased risk of muscle injury. Continue Reading

June 24, 2011 | Tags: Dangerous Drugs

Potential Zoloft Birth Lawsuit
As the birth defect risks associated with SSRI drugs such as Zoloft become more widely acknowledged, many women wonder whether the benefits of these medications outweigh the risks when taken during pregnancy. Continue Reading

June 21, 2011 | Tags: Birth Defects, Dangerous Drugs, Zoloft

Topamax Birth Defects Lawsuits
Growing reports link the anti-seizure drug Topamax (topiramate) to serious cleft palate and cleft lip birth defects, and a number of families are now filing Topamax birth defect lawsuits. Continue Reading

June 20, 2011 | Tags: Birth Defects, Dangerous Drugs, Topamax

High Doses may Increase Epilepsy Drug Birth Defect Risk
New research suggests that the risk of birth defects associated with epilepsy drugs, such as Topamax, Depakote, Epitol, Tegretol, and Lamictal, may increase with a higher dosage. Continue Reading

June 17, 2011 | Tags: Birth Defects, Dangerous Drugs, Topamax

Dangerous Lamictal Side Effects
The anti-seizure drug Lamictal has been shown by the FDA to cause aseptic meningitis and Stevens-Johnson Syndrome in some users. Continue Reading

June 16, 2011 | Tags: Dangerous Drugs

Zoloft Can Cause Birth Defects
SSRI antidepressants such as Zoloft have been linked to a number of birth defects such as Primary Persistent Pulmonary Hypertension (PPHN) and cardiac birth defects. Continue Reading

June 15, 2011 | Tags: Birth Defects, Dangerous Drugs, Zoloft

Cleft Lip and Cleft Palate Birth Defects
When taken during pregnancy, the anti-seizure drug Topamax has been found to increase the chance of having a child with a cleft lip or cleft palate birth defect. Continue Reading

June 14, 2011 | Tags: Birth Defects, Dangerous Drugs, Topamax

Birth Defects and Pain Medication
Results of a new CDC study about the link between opiod analgesic pain medications and birth defects was published in April 2011 in the American Journal of Obstetrics and Gynecology. Continue Reading

June 13, 2011 | Tags: Birth Defects, Dangerous Drugs

More Women Using Medications during Pregnancy
Despite limited information on the effects of prescription drugs on a developing baby, there has been an increase in the number of women taking prescription medications during pregnancy. Continue Reading

June 9, 2011 | Tags: Birth Defects, Dangerous Drugs, Paxil, Topamax, Zoloft

Lexapro Can Cause Birth Defects
The risk of serious birth defects has been linked to antidepressants such as Lexapro when taken during pregnancy. Continue Reading

June 8, 2011 | Tags: Birth Defects, Celexa, Dangerous Drugs, Lexapro, Zoloft

Miscarriage Risk is Doubled when Women Take Effexor
A recent study found that when women take SSRI and SNRI antidepressants, such as Effexor, during pregnancy they have a significantly higher risk of miscarriage. Continue Reading

June 7, 2011 | Tags: Birth Defects, Celexa, Dangerous Drugs, Lexapro, Zoloft

Heart Birth Defects and Antidepressants
In some cases, congenital heart defects can be caused when the mother takes antidepressants such as Zoloft during pregnancy. Continue Reading

June 6, 2011 | Tags: Birth Defects, Celexa, Dangerous Drugs, Lexapro, Zoloft

Zoloft Poses a Risk of Birth Defects
The antidepressant Zoloft poses a risk of serious and life-threatening birth defects when taken during pregnancy. Continue Reading

June 3, 2011 | Tags: Birth Defects, Dangerous Drugs, Zoloft

Celexa may Cause Birth Defects
A study links Celexa and other SSRI antidepressants to heart defects and other birth defects when taken during pregnancy. Continue Reading

June 2, 2011 | Tags: Birth Defects, Celexa, Dangerous Drugs

Paxil: Risk of Birth Defects
The FDA has ordered a stronger warning be placed on Paxil because it has been associated with heart birth defects. Continue Reading

June 1, 2011 | Tags: Birth Defects, Dangerous Drugs, Paxil

Wellbutrin and Birth Defects Risks
Recent studies have linked Wellbutrin to an increased risk of cardiac birth defects when taken during the first trimester. Continue Reading

May 31, 2011 | Tags: Birth Defects, Dangerous Drugs

Pre-Term Birth Risk Doubled by Antidepressants during Pregnancy

A new study finds that Zoloft, Paxil, and Prozac may double the risk of pre-term birth when taken by pregnant women. Continue Reading

May 23, 2011 | Tags: Birth Defects, Dangerous Drugs, Zoloft

Zoloft Side Effect: Heart Birth Defects
When taken during pregnancy, Zoloft may cause septal congenital heart birth defects. Continue Reading

May 19, 2011 | Tags: Birth Defects, Dangerous Drugs, Zoloft

Generic Celexa Recalled
Some bottles of generic Celexa and generic Propecia have been recalled after a labeling mix-up. Continue Reading

May 18, 2011 | Tags: Celexa, Dangerous Drugs

Risk of Ulcerative Colitis 4 Times Higher with Accutane Side Effects
A new study adds to the evidence that use of acne drug Accutane may increase the risk of serious bowel problems. Continue Reading

May 13, 2011 | Tags: Accutane, Dangerous Drugs

Tegretol Side Effects Include Spina Bifida when Taken During Pregnancy
A new study by European researchers links the epilepsy drug Tegretol to the risk of spina bifida birth defect when taken by women who are pregnant. Continue Reading

May 11, 2011 | Tags: Birth Defects, Dangerous Drugs

Johnson & Johnson Issues Topamax Recall for Some Bottles
Nearly 60,000 bottles of the epilepsy drug Topamax are being recalled as a result of reports of a musty odor that has affected a number of medications produced by Johnson & Johnson. Continue Reading

May 6, 2011 | Tags: Birth Defects, Dangerous Drugs, Topamax

Antidepressants that may Cause Birth Defects
A study in the New Entland Journal of Medicine links serious birth defects to antidepressant drugs. Continue Reading

May 4, 2011 | Tags: Celexa, Dangerous Drugs, Lexapro, Zoloft

Fosamax may lead to Femur Fracture
When patients use Fosamax, they have an increased risk of rare thigh bone (femur) fractures. Continue Reading

May 2, 2011 | Tags: Dangerous Drugs

New Diet Pill Linked to Topamax Birth Defects
A new long-term weight loss drug may pose a risk of cleft palate and cleft lip birth defects. Continue Reading

April 28, 2011 | Tags: Birth Defects, Dangerous Drugs, Topamax

SSRI Antidepressants can Cause Birth Defects
A study in the New England Journal of Medicine reports that newborns born to mothers who took SSRI antidepressants during pregnancy face a risk of Primary Pulmonary Hypertension (PPHN) that is six times greater... Continue Reading

April 22, 2011 | Tags: Birth Defects, Celexa, Dangerous Drugs, Lexapro, Paxil, Zoloft

Paxil Linked to Birth Defects: PPHN
The FDA issued a birth defect safety warning in 2006 regarding the antidepressant SSRI drug known as Paxil (paroxetine). Continue Reading

April 21, 2011 | Tags: Birth Defects, Dangerous Drugs, Paxil

Celexa Linked to Birth Defects
Celexa has been linked to a heightened risk of life-threatening birth defects, including Primary Pulmonary Hypertension (PPHN). Continue Reading

April 18, 2011 | Tags: Birth Defects, Celexa, Dangerous Drugs

How do Pharmaceutical Drugs Cause Birth Defects?
While most medications are safe to take during pregnancy, some drugs carry a risk of causing birth defects in children born to mothers who take these dangerous drugs during pregnancy. Continue Reading

April 15, 2011 | Tags: Birth Defects, Dangerous Drugs, Topamax

Antibiotic Drugs that Cause Birth Defects
Certain medications have been proven to cause birth defects in children born to mothers who took these dangerous drugs while they were pregnant. Continue Reading

April 14, 2011 | Tags: Birth Defects, Dangerous Drugs, Spina Bifida

Topamax May Cause Cleft Palate and Lip Birth Defects: Physician Warning
When pregnant women are given Topamax, cleft palate and cleft lip birth defects are a potential risk for their unborn children, warns a group representing family physicians across the United States. Continue Reading

April 12, 2011 | Tags: Birth Defects, Dangerous Drugs, Topamax

FDA Issues Topamax Birth Defect Warning
Topamax may increase the risk of birth defects, warn federal regulators.  When the epilepsy drug Topamax is taken by pregnant women, there is a danger that their newborns will suffer from cleft palate and cleft lip birth defects. Continue Reading

April 6, 2011 | Tags: Birth Defects, Dangerous Drugs, Topamax

Accutane may Exacerbate Celiac Disease
The side effects of acne medications Accutane and Retin-A may worsen celiac disease, a new medical study suggests. Continue Reading

March 25, 2011 | Tags: Accutane, Dangerous Drugs

Topamax May Cause Birth Defects
On Friday, March 6, the FDA announced through a drug safety communication that the epilepsy drug Topamax may increase the risk of birth defects when used by expecting mothers.  In particular, warns the FDA, Topamax may lead to cleft lip and cleft palate birth defects in newborns. Continue Reading

March 17, 2011 | Tags: Birth Defects, Dangerous Drugs, Topamax

Accutane, Sotret, Amnesteem and Claravis Linked to Ulcerative Colitis
A recent study published in The American Journal of Gastroenterology concluded that people who took Accutane, Sotret, Claravis or Amnesteen (Isotretinoin) were four (4) times more likely to develop Ulcerative Colitis, a serious form of Inflammatory Bowel Disease (IBD). Continue Reading

Feb. 1, 2011 | Tags: Accutane, Amnesteem, Claravis, Dangerous Drugs, Sotret

View All Legal News